Post-earnings recap
Reported
Mon, May 2, 2016
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
88%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Haemonetics Corp's earnings report indicates a disappointing quarter, particularly with the EPS falling short of expectations. The stock reacted negatively, dropping 14.74%, likely due to investor concerns over the company's performance and lack of guidance. The management's defensive tone suggests they are aware of the challenges ahead and are focusing on operational improvements.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.37 | N/A | -19.04% |
Management expressed concerns about current market conditions impacting performance. They are prioritizing operational improvements to address these challenges.
Management acknowledged the challenges faced during the quarter.
They emphasized a focus on improving operational efficiency moving forward.